(Q45306964)

11 December 2017

title

Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives (English)

1 reference

11 December 2017

0 references

1

1 reference

11 December 2017

Marios Panas

2

1 reference

11 December 2017

Nikolaos Kalfakis

series ordinal

3

1 reference

11 December 2017

Demetrios Vassilopoulos

series ordinal

4

1 reference

11 December 2017

publication date

19 November 2007

1 reference

Molecular Genetics and Metabolism

11 December 2017

published in

1 reference

11 December 2017

volume

93

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

341-346

1 reference

Role of cholesterol in synapse formation and function

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol for synthesis of myelin is made locally, not imported into brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Huntington's disease gene (IT15) is widely expressed in human and rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Increased rate of suicide among patients with Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

High suicidal ideation in persons testing for Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Low serum cholesterol concentration and risk of suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Biogenic amine turnover and serum cholesterol in suicide attempt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Apolipoprotein E genotyping by one-stage PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Unified Huntington's disease rating scale: Reliability and consistency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Huntington disease: Clinical care and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Violent behavior associated with hypocholesterolemia due to a novel APOB gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Genetic disorders of cholesterol biosynthesis in mice and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

CNS synaptogenesis promoted by glia-derived cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol and Alzheimer's disease--is there a relation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Huntington's disease mortality in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Causes of death in patients with Huntington's disease and in unaffected first degree relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol and mortality in heart failure: the bad gone good?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Relationship between plasma lipids and all-cause mortality in nondemented elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Invited commentary: low cholesterol and nonartherosclerotic disease risk: a persistently perplexing question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Serum Cholesterol Levels and the Risk of Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

Brain cholesterol: long secret life behind a barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.002

10.1016/J.YMGME.2007.10.002

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference